2nd TGF-β for Immuno-Oncology Drug Development Summit

Kongressthemen
From Cell Signaling to the Tumor Microenvironment, Exploit TGF-β’s Role in IO to Harness a Clinically Relevant, Safe & Efficacious Therapeutics

It is clear the world of TGF-β contains vast potential and excitement, in the past year alone we have seen great advances, clinical setbacks, and novel insights into the role of TGF-β.

Kongressorganizer (PCO)
Hanson Wade

https://go.evvnt.com/913463-1?pid=4832

Frau Erin Thomas